lobbying_activities: 2787007

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2787007	e6e53049-e7f7-4ac3-80cc-06cdd8e43bb6	Q1	AARP	1694	AARP	2022	first_quarter	PHA	No bill number. Discussed prescription drug legislation and policies to lower prescription drug prices. H.R.5376, the Build Back Better Act. S.3700/H.R.6833, the Affordable Insulin Now Act. No bill number. Discussed disclosure of prescription drug prices in television ads. No bill number. Discussed inappropriate use of antipsychotic drugs in nursing homes. H.R. 4356, the FY 2022 Agriculture, Rural Development & FDA Appropriations.	Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office		3530000	0	0	2022-04-19T16:23:06-04:00